Bank of Montreal’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.11M | Buy |
145,204
+140,827
| +3,217% | +$4.48M | ﹤0.01% | 1310 |
|
|
2026
Q1 | $116K | Sell |
4,377
-11,158
| -72% | -$327K | ﹤0.01% | 3095 |
|
|
2025
Q4 | $450K | Buy |
15,535
+10,539
| +211% | +$316K | ﹤0.01% | 2363 |
|
|
2025
Q3 | $139K | Sell |
4,996
-61,669
| -93% | -$1.56M | ﹤0.01% | 2886 |
|
|
2025
Q2 | $1.62M | Buy |
66,665
+58,421
| +709% | +$1.28M | ﹤0.01% | 1665 |
|
|
2025
Q1 | $171K | Sell |
8,244
-525
| -6% | -$13.2K | ﹤0.01% | 2775 |
|
|
2024
Q4 | $206K | Buy |
8,769
+2,488
| +40% | +$61.2K | ﹤0.01% | 2747 |
|
|
2024
Q3 | $161K | Sell |
6,281
-353
| -5% | -$8.99K | ﹤0.01% | 3108 |
|
|
2024
Q2 | $163K | Sell |
6,634
-100
| -1% | -$2.52K | ﹤0.01% | 3073 |
|
|
2024
Q1 | $192K | Sell |
6,734
-413
| -6% | -$12.4K | ﹤0.01% | 3066 |
|
|
2023
Q4 | $245K | Sell |
7,147
-1,444
| -17% | -$39.3K | ﹤0.01% | 2994 |
|
|
2023
Q3 | $268K | Buy |
8,591
+3,360
| +64% | +$110K | ﹤0.01% | 2892 |
|
|
2023
Q2 | $182K | Sell |
5,231
-475
| -8% | -$14.9K | ﹤0.01% | 3252 |
|
|
2023
Q1 | $172K | Buy |
5,706
+468
| +9% | +$14.5K | ﹤0.01% | 3080 |
|
|
2022
Q4 | $153K | Sell |
5,238
-114
| -2% | -$3.62K | ﹤0.01% | 3241 |
|
|
2022
Q3 | $191 | Sell |
5,352
-25,668
| -83% | -$942K | ﹤0.01% | 3228 |
|
|
2022
Q2 | $1.06K | Sell |
31,020
-85
| -0.3% | -$2.97K | ﹤0.01% | 2263 |
|
|
2022
Q1 | $1.54M | Sell |
31,105
-878
| -3% | -$41.9K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $2.01M | Buy |
31,983
+23,529
| +278% | +$1.63M | ﹤0.01% | 1581 |
|
|
2021
Q3 | $706K | Buy |
8,454
+739
| +10% | +$62K | ﹤0.01% | 2677 |
|
|
2021
Q2 | $727K | Buy |
7,715
+3,051
| +65% | +$259K | ﹤0.01% | 2648 |
|
|
2021
Q1 | $413K | Sell |
4,664
-21,394
| -82% | -$2.12M | ﹤0.01% | 2753 |
|
|
2020
Q4 | $2.72M | Buy |
26,058
+24,743
| +1,882% | +$1.97M | ﹤0.01% | 1690 |
|
|
2020
Q3 | $88K | Buy |
1,315
+835
| +174% | +$48.9K | ﹤0.01% | 3152 |
|
|
2020
Q2 | $28K | Hold |
480
| – | – | ﹤0.01% | 3694 |
|
|
2020
Q1 | $14K | Hold |
480
| – | – | ﹤0.01% | 3366 |
|
|
2019
Q4 | $16K | Hold |
480
| – | – | ﹤0.01% | 4400 |
|
|
2019
Q3 | $14K | Hold |
480
| – | – | ﹤0.01% | 4259 |
|
|
2019
Q2 | $17K | Hold |
480
| – | – | ﹤0.01% | 4258 |
|
|
2019
Q1 | $16K | Hold |
480
| – | – | ﹤0.01% | 3730 |
|
|
2018
Q4 | $12K | Hold |
480
| – | – | ﹤0.01% | 3826 |
|
|
2018
Q3 | $16K | Hold |
480
| – | – | ﹤0.01% | 3769 |
|
|
2018
Q2 | $14K | Sell |
480
-10,998
| -96% | -$306K | ﹤0.01% | 3854 |
|
|
2018
Q1 | $296K | Buy |
+11,478
| New | +$311K | ﹤0.01% | 2446 |
|
Other funds holding ARKG
Bank of Montreal's ARKG Position: Q2 2026 in Review
Bank of Montreal increased its ARK Genomic Revolution ETF (ARKG) stake by 3,217% in Q2 2026, buying an estimated $4.48M and bringing the position to 145,204 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.
Bank of Montreal first reported a position in ARKG in Q1 2018 and has held it in 34 quarters since. 259 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Bank of Montreal held 145,204 shares of ARK Genomic Revolution ETF worth $6.11M as of Q2 2026.
- Bank of Montreal bought 140,827 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $4.48M.
- ARK Genomic Revolution ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1310 holding.
- Bank of Montreal first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 34 quarters since.
- 259 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.